Form 4: Amedisys Director, Teresa L. Kline, Awarded Restricted Stock Units

Director Teresa L. Kline received 1,690 restricted stock units from Amedisys Inc. on May 3, 2025, which will vest on May 3, 2026, contingent upon continued service on the Board of Directors.

Summary

• Teresa L. Kline, a director of Amedisys Inc. (AMED), was awarded 1,690 time-based Restricted Stock Units (RSUs) on May 3, 2025.
• Each RSU represents a contingent right to receive one share of Amedisys' common stock.
• The RSUs will vest 100% on May 3, 2026, provided Kline continues to serve as a non-employee member of the Issuer's Board of Directors through the vesting date.
• Following the transaction, Kline beneficially owns 9,818 shares of Amedisys common stock directly.

Sentiment

Score: 7

Explanation: The document reflects a standard transaction of awarding stock to a director, which is generally viewed neutrally to positively as it aligns interests. There are no red flags or negative implications.

Positives

• The awarding of restricted stock units to a director aligns their interests with those of the shareholders.
• Continued service requirement for vesting incentivizes the director to remain engaged with the company.

Future Outlook

The vesting of the RSUs is contingent upon the Reporting Person's continued service as a non-employee member of the Issuer's Board of Directors through the vesting date.

Industry Context

Stock awards to board members are a common practice in publicly traded companies to align the interests of directors with those of shareholders and incentivize their continued service.

Comparison to Industry Standards

• Equity compensation for board members is a standard practice across the healthcare industry.
• Companies like UnitedHealth Group (UNH) and Humana (HUM) also utilize stock options and restricted stock units as part of their director compensation packages.
• The size of the award is typical for non-executive directors in companies of Amedisys' size and market capitalization.

Stakeholder Impact

• The stock award aligns the director's interests with shareholders, potentially leading to better governance and decision-making.
• The vesting requirements incentivize the director's continued service, which benefits the company and its stakeholders.

Key Dates

Keywords

Amedisys, Director, Restricted Stock Units, RSU, Beneficial Ownership, Form 4, AMED